Publication: The CD11a and Endothelial Protein C Receptor Marker Combination Simplifies and Improves the Purification of Mouse Hematopoietic Stem Cells
Open/View Files
Date
2018
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley and Sons Inc.
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Karimzadeh, Alborz, Vanessa M. Scarfone, Erika Varady, Connie Chao, Karin Grathwohl, John W. Fathman, David A. Fruman, Thomas Serwold, and Matthew A. Inlay. 2018. “The CD11a and Endothelial Protein C Receptor Marker Combination Simplifies and Improves the Purification of Mouse Hematopoietic Stem Cells.” Stem Cells Translational Medicine 7 (6): 468-476. doi:10.1002/sctm.17-0189. http://dx.doi.org/10.1002/sctm.17-0189.
Research Data
Abstract
Abstract Hematopoietic stem cells (HSCs) are the self‐renewing multipotent progenitors to all blood cell types. Identification and isolation of HSCs for study has depended on the expression of combinations of surface markers on HSCs that reliably distinguish them from other cell types. However, the increasing number of markers required to isolate HSCs has made it tedious, expensive, and difficult for newcomers, suggesting the need for a simpler panel of HSC markers. We previously showed that phenotypic HSCs could be separated based on expression of CD11a and that only the CD11a negative fraction contained true HSCs. Here, we show that CD11a and another HSC marker, endothelial protein C receptor (EPCR), can be used to effectively identify and purify HSCs. We introduce a new two‐color HSC sorting method that can highly enrich for HSCs with efficiencies comparable to the gold standard combination of CD150 and CD48. Our results demonstrate that adding CD11a and EPCR to the HSC biologist's toolkit improves the purity of and simplifies isolation of HSCs. stem cells translational medicine 2018;7:468–476
Description
Other Available Sources
Keywords
Tissue-specific Progenitor and Stem cells, Hematopoietic Stem/Progenitor Cells, Hematopoietic Disorders, Graft vs Host Disease, Hematopoietic Regeneration, Novel Cell Markers, Tissue‐Specific Progenitor and Stem Cells, Hematopoietic stem cells, Bone marrow transplantation, Cell surface markers, long‐term repopulation
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service